Seagen Inc (NASDAQ:SGEN)
| 179.28 Delayed Data As of Jun 24 |  +5.28 / +3.03%Today’s Change | 105.43 Today|||52-Week Range 192.79 | +15.96% Year-to-Date |
Latest SGEN News | Press Releases
| Should You Sell Biotech Stocks If There's a Recession? Jun 23 / MotleyFool.com - Paid Partner Content | Seattle Genetics (SGEN) Moves 12.7% Higher: Will This Strength Last? Jun 20 / Zacks.com - Paid Partner Content |
| 3 Stocks That Drove the Dow's 641-Point Gain Jun 21 / MotleyFool.com - Paid Partner Content | Why Seagen Surged Today Jun 17 / MotleyFool.com - Paid Partner Content |
| Seagen (SGEN) Stock Up on Rumors of Acquisition by Merck Jun 20 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 174.00 |
| Today’s open | 179.69 |
| Day’s range | 173.67 - 179.91 |
| Volume | 134,164 |
| Average volume (3 months) | 1,247,382 |
| Market cap | $33.0B |
Data as of 4:01pm ET, 06/24/2022
Growth & Valuation
| Earnings growth (last year) | -205.55% |
| Earnings growth (this year) | +6.13% |
| Earnings growth (next 5 years) | +23.00% |
| Revenue growth (last year) | -27.63% |
| P/E ratio | NM |
| Price/Sales | 17.88 |
| Price/Book | 11.95 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| --Actelion Ltd | 0.00 | 0.00% |
| ---- | ||
| TAKTakeda Pharmaceutica... | 0.00 | 0.00% |
| CTLTCatalent Inc | 0.00 | 0.00% |
Data as of 4:54pm ET, 06/24/2022
Financials
| Next reporting date | July 28, 2022 |
| EPS forecast (this quarter) | -$0.85 |
| Annual revenue (last year) | $1.6B |
| Annual profit (last year) | -$674.5M |
| Net profit margin | -42.84% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Bothell, Washington |
Forecasts
